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Abstract 
Cardiovascular disease is a leading cause of death worldwide. Human pluripotent stem cell-derived 
cardiomyocytes (hPSC-CMs) hold immense clinical potential and recent studies have enabled 
generation of virtually pure hPSC-CMs with high efficiency in chemically defined and xeno-free 
conditions. Despite these advances, hPSC-CMs exhibit an immature phenotype and are 
arrhythmogenic in vivo, necessitating development of strategies to mature these cells. hPSC-CMs 
undergo significant metabolic alterations during differentiation and maturation. A detailed analysis 
of the metabolic changes accompanying maturation of hPSC-CMs may prove useful in identifying 
new strategies to expedite hPSC-CM maturation and also may provide biomarkers for testing or 
validating hPSC-CM maturation. In this study we identified global metabolic changes which take 
place during long-term culture and maturation of hPSC-CMs derived from three different hPSC 
lines. We have identified several metabolic pathways, including phospholipid metabolism and 
pantothenate and Coenzyme A metabolism, which showed significant enrichment upon 
maturation in addition to fatty acid oxidation and metabolism. We also identified increases in 
glycerophosphocholine and the glycerophosphocholine:phosphocholine ratio as potential 
metabolic biomarkers of maturation. These biomarkers were also affected in a similar manner 
during murine heart development in vivo. These results support that hPSC-CM maturation is 
associated with extensive metabolic changes in metabolic network utilization and understanding 
the roles of these metabolic changes has the potential to develop novel approaches to monitor and 
expedite hPSC-CM maturation. 
Key words: Human Pluripotent Stem Cells, Cardiomyocytes, Maturation, Metabolomics, Biomarkers. 
Introduction 
The ability of human pluripotent stem cells 
(hPSCs) to self-renew indefinitely and differentiate to 
different cell types in the body makes them a valuable 
source of cells for therapeutic applications and in vitro 
human tissue models for drug discovery [1]. Our 
group has recently reported protocols for directed 
differentiation of hPSCs to functional beating 
cardiomyocytes (CMs) with high efficiency (>95%) in 
xeno-free conditions [2–4]. hPSC-derived CMs 
(hPSC-CMs) can be enriched by culture in 
glucose-depleted and lactate-rich culture medium [5] 
to generate virtually pure populations of beating 
CMs. Despite these advances, the applications of 
hPSC-derived CMs (hPSC-CMs) in disease modeling 
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and clinical applications is limited by relatively 
immature structural and functional properties of the 
differentiated hPSC-CMs [6, 7]. Lundy et al. [8] and 
Kamakura et al. [9] have shown that long-term culture 
(90-180 days) of hPSC-CMs in vitro induces significant 
differences from those cultured for shorter time (20-40 
days) and importantly, these older hPSC-CMs exhibit 
adult-like CM properties, including an increase in cell 
size and aniosotropy, organized sarcomere structure 
with higher myofibrillar density and alignment, and 
slower contraction kinetics as compared to younger 
hPSC-CMs. This long-term culture of hPSC-CMs 
improves cell quality but extends the cell production 
pipeline, complicating utilization of these cells in 
industrial and clinical applications [6, 7]. Identifying 
and monitoring the differences between immature 
and mature CMs is a crucial step to developing 
strategies to expedite the maturation process of 
hPSC-CMs [7].  
One challenge in developing processes to mature 
hPSC-CMs is that there is no single physiological 
property or parameter which has been established as 
a benchmark or biomarker for maturation. One of the 
key differences between adult CMs and fetal CMs is 
the utilization of fatty acids for energy generation in 
mature CMs [10]. CM maturation is accompanied by 
changes in several transcriptional regulators 
including hypoxia inducing factor-1α (HIF-1α), 
peroxisome proliferator-activated receptor (PPAR) 
gamma coactivator 1-alpha (PGC-1α)/PPARα, and 
PGC-1α/PPARδ, which leads to global changes in 
expression of several proteins involved in energy 
metabolism including glycolysis and fatty acid 
oxidation [10, 11]. 
In this study, we identified time-dependent 
metabolic changes in hPSC-CMs differentiated from 
three different human embryonic and induced 
pluripotent stem cell lines. 3 month (3m) hPSC-CMs 
showed significant morphological, molecular, and 
metabolic maturation as compared to 1 month (1m) 
hPSC-CMs. Global metabolic profiling revealed 
substantial time-dependent metabolic changes 
associated with long-term culture and maturation. We 
identified several metabolic pathways, including the 
glycerol phosphate shuttle, pantothenate and 
Coenzyme A (CoA) biosynthesis, and sphingolipid 
metabolism in addition to beta oxidation of fatty 
acids, to be enriched in 3m hPSC-CMs compared to 
1m hPSC-CMs. Biomarker analysis revealed several 
metabolites with the potential to distinguish between 
1m and 3m hPSC-CMs. Of particular interest were 
glycerophosphocholine (GPC) and GPC to 
O-phosphocholine (PC) ratio, both of which increased 
in 3m hPSC-CMs as compared to 1m hPSC-CMs and 
day 6 cardiac progenitors. These changes in GPC and 
GPC:PC were also observed during murine heart 
development in vivo. Overall this study provides 
insights into specific metabolic alterations during 
time-dependent maturation of hPSC-CMs which can 
be used to test and validate strategies to expedite the 
maturation of hPSC-CMs. This study also highlights 
the significance of metabolic profiling in identifying 
novel pathways which may be involved in inducing 
or maintaining hPSC-CM maturation.  
Materials and Methods 
Cell culture 
hPSCs were maintained in mTeSR1 medium 
(STEMCELL Technologies) on Matrigel- (BD 
Biosciences) coated plates according to previously 
published methods [2–4]. Cardiac differentiation was 
performed following the protocol described by Lian et 
al. [4]. hPSC-CMs were maintained in RPMI (Life 
Technologies) supplemented with B-27 supplement 
(Life Technologies). B-27 supplement without insulin 
(Life Technologies) was used from day 0 to day 6 of 
differentiation. CHIR99021 (Selleckchem) and IWP2 
(Tocris) were added at day 0 and day 3, respectively, 
according to the protocol.  
Mouse maintenance and heart isolation 
All experiments were performed in accordance 
with the National Institute of Health (NIH) Guide for 
the Care and Use of Laboratory Animals and were 
approved by the Animal Care and Use Committee at 
the University of Wisconsin-Madison. 20 days old and 
3 month old C57BL/6J wild-type mice were 
euthanized using CO2 chamber. Hearts were quickly 
removed and rinsed in ice-cold phosphate-buffered 
saline (PBS). The hearts were then snap frozen in 
liquid nitrogen, and stored at -80 oC. The atria were 
later removed from 3 month old mouse heart before 
sample metabolite extraction using chloroform, 
methanol, and water extraction method.  
Immunostaining  
hPSC-CMs were re-plated at different time 
points on a 24-well Matrigel-coated plate and 
immunostaining was performed using the same 
reagents and antibodies used by Lian et al. [2, 4] 
(Supplementary Table 1). Single cell imaging was 
performed on an epifluorescence microscope (DM 
IRB; Leica) with a QImaging® Retiga 4000R camera.  
Flow Cytometry 
Cells were singularized with Accutase (Life 
Technologies) for 10-20 mins and then fixed with 1% 
paraformaldehyde for 20 min at room temperature 
and stained with primary and secondary antibodies 
(Supplementary Table 1) in phosphate buffered saline 
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(PBS) (Life Technologies) plus 0.1% Triton X-100 and 
0.5% bovine serum albumin (BSA) (AlbuMAX II). 
Data were collected on a FACSCaliber flow cytometer 
(Beckton Dickinson) and analyzed using FlowJo [12].  
Mitochondrial respiration assay 
The Seahorse XF96 extracellular flux analyzer 
was used to study oxygen consumption rate (OCR) 
and assess mitochondrial function. The protocol was 
similar to that described by Kuppusamy et al. [13] 
with minor modifications. The plates were pre-treated 
with 0.1% gelatin. Both 1m and 3m hPSC-CMs were 
seeded onto the plates at a density of 30,000 cells per 
XF96 well (2,500/mm2). The Seahorse assays were 
performed 3 days after the seeding onto the XF96 well 
plate. One hour before the assay, culture media were 
exchanged for base media (unbuffered DMEM 
(Seahorse XF Assay Media) supplemented with 1 mM 
sodium pyruvate (Life Technologies) and with 25 mM 
glucose (for MitoStress assay)). 15 min prior to 
starting the assay, we added etomoxir (ETO) (final 
concentration 50 µM) or DMSO (stock solution 
prepared in Seahorse XF assay media) to the wells. 
Substrates and inhibitors were injected during the 
measurements to achieve final concentrations of 
4-(trifluoromethoxy) phenylhydrazone at 1 μM 
(FCCP; Seahorse Biosciences), oligomycin (2.5 μM), 
antimycin (2.5 μM) and rotenone (2.5 μM) for the 
MitoStress assay. Maximal OCR is defined as the 
change in OCR in response to FCCP compared to 
OCR after the addition of oligomycin. The reagents 
were from Sigma, unless otherwise indicated.  
NMR sample preparation  
For in vitro hPSC-CMs, sample collection was 
performed as described in our previous studies [14, 
15]. Briefly, the cells in 1 well from a 12 well plate 
(~1-2 million) were washed twice with ice-cold PBS 
(pH 7.4) and then the cells were quenched using 3 ml 
methanol as it gives better extraction efficiency and 
provides more rapid quenching as compared to other 
methods [16]. The cells were then detached using a 
cell scraper and pipetted into a 50 ml centrifuge tube. 
A dual phase extraction procedure adopted from 
Martineau et al. [17] was used to extract the 
intracellular metabolites. Briefly, the quenched cells 
were suspended in a mixture of chloroform, methanol 
and water in the ratio of 6:6:5.4 to achieve a final 
volume of 17.4 ml. After centrifugation for 15 min at 
3600 rpm, only the upper aqueous layer was used for 
further analysis and the organic phase was discarded. 
Metabolites from mouse heart tissue were extracted 
using the chloroform water methanol protocol for 
simultaneous extraction of polar and non-polar 
metabolites described by Beckonert et al. [18]. Only the 
aqueous phase was collected and used for further 
analysis. The aqueous phases from samples were 
dried at 30 °C using a centrifugal vacuum 
concentrator and stored at -80 °C until NMR analysis. 
Prior to NMR analysis, the samples were 
reconstituted in 0.6 ml of 0.1 M phosphate buffered 
D2O (pH = 7.0) solution containing 0.5 mM 
3-trimethylsilyl-propionate-2, 2, 3, 3,-d4 (TMSP, δ = 
0.0 ppm) as an internal standard and 0.2% w/v 
sodium azide. The samples were centrifuged at 18,000 
g for 10 min and 550 μl of the supernatant was 
transferred to 5 mm NMR tubes (Norell Inc.). 
NMR Acquisition 
1H NMR spectra were recorded at 298 K on a 
Bruker Avance III equipped with a 5 mm cryogenic 
probe operating at 500 MHz (11.74 T). 1D spectra were 
acquired using standard NOESYPR1D pulse sequence 
(RD-90°-t1-90°-tm-90°-acquire) with a relaxation 
delay of 1 s, a mixing time of 100 ms and a pre-scan 
delay of 30 μs. Each spectrum consisted of 128 
transients or free induction decays (FIDs) collected 
into 48 k complex data points with a spectral width of 
12 ppm and an acquisition time of 4 s. Prior to Fourier 
transformation, the FIDs were zero-filled to 128 k data 
points and multiplied by an exponential window 
function (Line broadening factor (LB) = 0.5 Hz). The 
chemical shifts were referenced to the TMSP peak (δ = 
0 ppm), using TopSpinTM software (version 3.1, 
Bruker). 
Data Processing and Statistical Analysis 
Spectra were exported to an ACD/1D NMR 
Processor (Advanced Chemistry Development) for 
phasing, baseline correction, and solvent region 
removal (water: 4.7-5.1 ppm and DMSO: 2.72-2.75 
ppm). The peaks were annotated through the HMDB 
[19] and Metabohunter [20] and targeted profiling [21] 
was accomplished using ChenomX NMR Suite 
Profiler (version 7.7, ChenomX Inc.). The 
concentrations were referenced to a TMSP 
concentration of 0.5 mM. Over 95% of the peaks were 
assigned to metabolites available in the ChenomX 
library and the quantified metabolite concentrations 
were exported to an Excel file (Microsoft). First, the 
metabolites with low confidence in fitting with 
confounding peaks due to high overlap or very low 
abundance were excluded from the analysis. These 
included glucose, tryptophan, guanidoacetate, 
beta-alanine, and malate. The concentration data 
matrix was further normalized by the total 
concentration of metabolites in each sample to 
evaluate the metabolite fractions and also to account 
for the differences in efficiencies of extraction [14, 15, 
22]. The concentration data table was processed for 
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statistical analysis using MetaboAnalyst [23, 24] and 
GENE-E [25]. Hierarchical clustering was performed 
on auto-scaled concentration data (mean centering 
followed by dividing by the standard deviation) and 
two way analysis of variance (ANOVA) was used to 
identify significantly altered metabolites (p < 0.05). 
Pathway enrichment analysis was performed in 
MetaboAnalyst’s pathway analysis module. Pathways 
with a false discovery rate (FDR) < 0.1 and p < 0.05 
were considered to be significantly enriched. 
Univariate biomarker analysis was performed using 
MetaboAnalyst’s biomarker analysis module. 
Metabolite-metabolite correlation analysis (MMCA) 
was performed on Pearson correlation data extracted 
from correlation analysis module in MetaboAnalyst 
using either 1m hPSC-CMs or 3m hPSC-CMs alone 
and the network visualization was performed using 
Metscape [26] plugin in Cytoscape [27]. Correlation 
coefficients corresponding to p < 0.01 were considered 
to be significant. The NMR spectral files and 
processed JCAMP files are available on the 
MetaboLights database (study ID: MTBLS425) [28]. 
Raw input data for the analysis and output from each 
analysis module is provided in Supplementary Table 
1. Student’s t-test was used for comparisons between 
two groups while one way ANOVA with Tukey’s 
honest significant difference (HSD) test as post hoc 
method was used for multiple comparisons, unless 
otherwise indicated.  
Results and Discussion 
Extended culture of hPSC-CMs results in 
matured phenotypes 
The goal of this study was to identify metabolic 
pathways and metabolic biomarkers representative of 
maturation of hPSC-CMs. We first validated that 
extended culture of hPSC-CMs in vitro resulted in 
structural and phenotypic maturation, as reported in 
the literature [8, 9]. H9 human embryonic stem cells 
were differentiated to cardiomyocytes via the GiWi 
directed differentiation protocol [2–4] and maintained 
in culture in RPMI supplemented with B27 on 
Matrigel-coated plates for 1 month (1m) or 3 months 
(3m) starting from initiation of differentiation. We 
selected these time points to mimic the early 
hPSC-CMs (day 30) which possess embryonic-like 
electrophysiology and late hPSC-CMs (day 90) which 
show more adult-like electrophysiology [8, 9]. We 
performed immunostaining of cytoskeletal structures 
to study the differences in sarcomere organization 
and morphology of CMs (Fig. 1). We observed distinct 
differences in morphology and aspect ratio of 3m 
hPSC-CMs as compared to 1m hPSC-CMs (Fig. 1A-D). 
Myofibrils were more aligned in 3m hPSC-CMs as 
compared to 1m hPSC-CMs based on 
immunostaining for α-actinin, F-actin and cTnT (Fig. 
1A). 3m hPSC-CMs also possessed a significantly 
larger perimeter (p<1E-9), area (p<1E-6), and 
significantly lower circularity (p<1E-6) compared to 
1m hPSC-CMs (Fig. 1B-D). In addition, 3m hPSC-CMs 
were less proliferative than 1m hPSC-CMs, assessed 
by Ki-67 staining (Fig. 1E-F). This observed structural 
maturation and decrease in proliferative capacity is 
consistent with maturation during extended culture 
reported in other studies [8, 9].  
One of the key differences between immature 
and mature CMs is that the metabolism in mature and 
adult CMs primarily utilizes fatty acid oxidation 
while immature and neonatal CMs use glucose and 
the citric acid cycle as their primary source of energy 
generation [6]. We performed a Seahorse Assay to 
quantify the oxygen consumption rate (OCR) in the 
presence and absence of ETO, an irreversible inhibitor 
of carnitine palmitoyltransferase-1 (CPT-1) which 
blocks the transport of fatty acyl chains from the 
cytoplasm to the mitochondrial intermembrane space, 
thereby blocking fatty acid oxidation. We observed 
significantly reduced basal OCR due to ETO 
treatment exclusively in 3m hPSC-CMs, highlighting 
that these cells utilize endogenous fatty acid oxidation 
as a fuel to fulfill their energy requirements (Fig. 1G). 
Additionally, the maximal mitochondrial respiration 
rate in the absence of ETO was two-fold higher in 3m 
hPSC-CMs than in 1m hPSC-CMs (Fig. 1H). Increased 
maximal respiration rate could be attributed to 
increased efficiency of energy generation or increased 
mitochondrial copy number [13]. Mitochondrial copy 
number was similar in 1m hPSC-CMs and 3m 
hPSC-CMs assessed by RT-PCR and quantitative 
RT-PCR (Supplementary Fig. S1). These results 
demonstrate that 3m hPSC-CMs use endogenous fatty 
acids as a fuel to fulfill their energy requirements, 
consistent of metabolic maturation of CMs [7].  
Ventricular maturation was tested by staining 
for myosin light chain atrial (MLC2a) and ventricular 
(MLC2v) expression (Fig. 2). We observed a greater 
proportion of cells expressing MLC2v (p<0.05) and 
fewer cells expressing MLC2a (p<0.05) in 3m 
hPSC-CMs as compared to 1m hPSC-CMs. Thus, the 
increased MLC2v/MLC2a in 3m hPSC-CMs is 
consistent with maturation of ventricular CMs [9] 
(Fig. 2). Based on these data, we conclude that 3m 
hPSC-CMs show significant morphological, 
molecular, and metabolic maturation as compared to 
1m hPSC-CMs.  
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Figure 1. Long term culture of hPSC-CMs induces morphological and metabolic maturation. (A) H9 hESCs were differentiated to CMs and maintained in RPMI 
supplemented with B27 for 1 month (1m) or 3 months (3m). Single cells were replated on Matrigel-coated 12 well plates and maintained in the same medium for 3 
days prior to immunofluorescent staining for α-actinin, F-actin and cTnT. Representative images are shown. Scale bars, 25 µm. Cell morphological parameters 
including (B) cell perimeter (µm), (C) cell area (µm2), and (D) cell circularity which was defined as 4*π*Area/(Perimeter)2 was calculated using immunostaining images 
and ImageJ software (N=112 from two independent replicates). (E) Cells were analyzed for Ki-67 and MF20 at indicated time points using flow cytometry and (F) 
quantification of flow cytometry data using three biological replicates. (G) OCR profiles of hPSC-CMs either pretreated with ETO or DMSO (control) in response to 
oligomycin, FCCP, and rotenone and antimycin (Rtn/AA) using the Seahorse flux analyzer (*p<0.05 between 3m CM-ETO and 3m CM+ETO). (H) Maximal respiration 
rate defined as the difference between the OCR after addition of FCCP and OCR after addition of oligomycin to 1m and 3m hPSC-CMs (*p<0.05). Data represent 
mean +/- S.E.M. from at least three biological replicates.  
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Figure 2. Long term culture of hPSC-CMs induces ventricular maturation. (A) Representative immunostaining for MLC2v and MLC2a in 1m and 3m hPSC-CMs (Scale 
bars, 25 µm). (B) Quantification of percentage of cells expressing MLC2v, MLC2a or double positive for MLC2v and MLC2a assessed by examination of 
immunostaining images. Data were collected from two replicates for 1m and 3m hPSC-CMs, with N>120 in each sample. *p<0.05 comparing 1m and 3m hPSC-CMs.  
 
Long-term culture of hPSC-CMs induces 
significant changes in metabolite 
concentrations 
To identify the specific metabolic changes in 
hPSC-CMs due to long-term culture in vitro, we 
performed NMR-based quantitative and targeted 
metabolic profiling [21] on intracellular metabolites of 
day 6 cardiac progenitors, day 30 immature 
hPSC-CMs, and day 90 mature hPSC-CMs. Human 
induced pluripotent stem cells (19-9-7) and human 
embryonic stem cells (H9 and ES03) were 
differentiated to cardiomyocytes using the GiWi 
directed differentiation protocol and maintained in 
culture for 1m or 3m from initiation of differentiation. 
We used three parent hPSC lines to identify global 
and stem cell line-independent metabolic changes due 
to maturation induced by long-term culture of 
hPSC-CMs. Fig. 3A shows the heatmap of all 
metabolites detected and clustering was performed 
using Pearson’s distance measure and Ward’s linkage 
criteria. We observed that day 6 cardiac progenitors 
derived from different parent stem cell lines clustered 
together and separated from 1m and 3m hPSC-CMs, 
which also formed distinct clusters. Day 6 cardiac 
progenitor cells are mainly non-contracting 
Isl1+Nkx2.5+ cells and can form different cell types in 
the heart, including CMs [2–4] and epicardial cells [29, 
30], upon addition of relevant signals. We performed 
partial least squares-discriminant analysis (PLS-DA), 
a supervised clustering and data reduction method, to 
identify the similarities and differences between the 
samples (Fig. 3B). We observed that time-dependent 
metabolic differences were dominant and captured 
along the first component (x-axis) while the parent 
stem cell line-specific differences were relatively 
minor, suggesting that majority of the metabolic 
changes are independent of parent stem cell line (Fig. 
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3B). An evaluation of prediction accuracy and 
cross-validation was performed to test the 
significance of the PLS-DA model (Supplementary 
Fig. S2). The metabolites which had highest 
importance in the first component (time-dependent) 
as calculated by variable importance in projection 
(VIP score) in the PLS-DA model are shown in Fig. 3C. 
The top metabolites, which had a VIP score greater 
than 1.6, were sn-glycero-3-phosphocholine (GPC), 
O-phosphocholine (PC), fumarate, carnitine and 
pantothenate.  
 
 
Figure 3. Metabolomics reveal global time-dependent metabolic changes in hPSC-CMs. Three different parent hPSC lines (H9, ES03, 19-9-7) differentiated to either 
day 6 (D6) cardiac progenitors or to CMs and maintained in culture for 1 month (1m) and 3 months (3m). NMR analysis was performed on cell lysates and 
concentration data were auto-scaled prior to analysis. (A) Hierarchical clustering was performed using Pearson distance measure and Ward’s linkage. (B) PLS-DA 
scores plot showing the two components accounting for highest variance on x and y axes. Each data point on the plot represents a unique biological sample and 
ellipses represent 95% confidence intervals. (C) Variable importance in projection (VIP) scores for top 15 metabolites along the first component which account for 
culture time-dependent metabolic changes. Colors represent average concentrations from three biological replicates.  
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We next performed two-way ANOVA to identify 
statistically significant metabolic changes due to two 
factors: a) time in culture and b) parent stem cell line 
and we observed that while there were some 
metabolites whose concentrations differed with 
parent stem cell line, the majority of the significant 
changes were associated with time in culture (Table 
1). Since the focus of this study is to determine the 
global metabolic changes associated with maturation 
due to long term culture, we focus on these 
time-dependent metabolic changes that were 
conserved in all three hPSC lines studied.  
Long term culture of hPSC-CMs led to 
significant changes in metabolic pathways 
The steady-state metabolite concentration 
changes can be useful in identifying potential 
metabolic pathways which are altered or enriched in 
CMs after extended culture. We performed MMCA to 
support that maturation leads to significant metabolic 
changes and to compare the underlying physiological 
metabolic states in 1m and 3m hPSC-CMs. MMCA 
allows us to identify the homeostatic variations which 
maintain the metabolism in steady-state and can 
provide information about the physiological state of 
the system [31–33]. We applied MMCA in 1m and 3m 
hPSC-CMs individually to study the correlation 
networks at these time points (Fig. 4). We set the 
threshold of absolute Pearson correlation coefficient 
to 0.8 (p<0.01). In 1m hPSC-CMs, we observed two 
clusters connected by GPC, N-acetylaspartate and 
threonine (Fig. 4A). The first cluster (left) contained 
amino acids and their derivatives, pantothenate (Vit. 
B5), and lactate. The second cluster (right) consisted of 
several metabolites related to pyruvate metabolism 
including pyruvate, acetate, formate, succinate, and 
fumarate. In 3m hPSC-CMs, we observed three 
separate correlation networks (Fig. 4B) with 
significant differences in correlation network 
topology as compared to 1m hPSC-CMs. While 1m 
hPSC-CMs showed significant and high correlations 
between most of the essential and non-essential amino 
acids and their derivatives, 3m hPSC-CMs showed a 
weaker correlation and amino acids no longer 
exhibited a high correlation with each other. We also 
observed increased connectivity for phospholipid 
metabolism related metabolites including choline, 
O-acetylcarnitine (ALCAR), O-phosphoethanolamine 
(PE), glycerol, and GPC in the MMCA network for 3m 
hPSC-CMs. While we observed several differences in 
overall correlation networks between 1m and 3m 
hPSC-CMs, some correlations were conserved 
including those between the branched chain amino 
acids valine, leucine and isoleucine. The top 20 
metabolites whose Pearson correlation coefficients 
exhibited changes in 1m hPSC-CMs vs. 3m hPSC-CMs 
are shown in Table 2. These significant changes in 
correlations between metabolites in hPSC-CMs after 
1m and 3m further highlight that extended culture 
induces significant changes in metabolic homeostasis. 
We identified several correlation subnetworks which 
were altered significantly, including those between 
amino acids and central metabolism-related 
metabolites including pyruvate, acetate, and formate. 
Since these correlation networks capture the potential 
changes in relationships between metabolites and 
underlying metabolic pathways [31–33], this could 
imply that metabolic pathways involving pyruvate 
and glucose metabolism, whose metabolites showed 
high correlations in 1m hPSC-CMs, were significantly 
altered after long term culture in 3m hPSC-CMs. 
Additionally, a subnetwork related to phospholipid 
metabolism was observed in 3m hPSC-CMs which 
suggests increased relevance of this metabolic 
pathway in mature CMs.  
We next identified the metabolic pathways 
enriched in both 1m and 3m hPSC-CMs as compared 
to day 6 cardiac progenitors. We performed 
comparative differential enrichment analysis to 
identify those pathways which were significantly 
enriched in either 1m or 3m hPSC-CMs (Fig. 5, 
Supplementary Table 1). We observed significant 
enrichment (FDR<0.1 and p<0.05) in beta oxidation of 
branched and very long chain fatty acids exclusively 
in 3m hPSC-CMs relative to day 6 progenitors and not 
in 1m hPSC-CMs relative to day 6 progenitors. We 
also observed that the enrichment score in 3m 
hPSC-CMs relative to day 6 progenitors for pyruvate 
metabolism and alanine metabolism was lower as 
compared to the enrichment score in 1m hPSC-CMs 
relative to day 6 progenitors. Increased expression in 
genes and proteins involved in fatty acid metabolism 
and reduced expression of components of glucose 
metabolism have been associated with maturation [6, 
7], and here we show that these pathways are also 
significantly affected at the level of metabolites. In 
addition, we also identified metabolic pathways 
which have not previously been associated with CM 
maturation that showed significant enrichment in 3m 
hPSC-CMs, including taurine metabolism, glycerol 
phosphate shuttle, nicotinate and nicotinamide 
metabolism, biotin metabolism, lysine degradation, 
pantothenate and CoA biosynthesis, beta-alanine 
metabolism, and sphingolipid metabolism. Some of 
these enriched pathways were related to cofactor 
metabolism, including pantothenate and CoA 
biosynthesis, biotin metabolism, and beta-alanine 
metabolism, further highlighting significant changes 
in metabolic utilization and demand as hPSC-CMs 
age in culture. Another group of pathways, which 
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includes glycerol phosphate shuttle and sphingolipid 
metabolism, are associated with cell membrane and 
phospholipid synthesis and were exclusively enriched 
in 3m hPSC-CMs compared to day 6 progenitors and 
not in 1m hPSC-CMs relative to day 6 progenitors. 
These data demonstrate that long term culture of 
hPSC-CMs led to significant changes in metabolic 
pathways. The implications of the enrichment in the 
aforementioned metabolic pathways during 
maturation and their potential significance for 
accelerating maturation should be investigated in 
future mechanistic studies.  
 
 
Long-term culture of hPSC-CMs is associated 
with a switch from phosphocholine to 
glycerophosphocholine  
We next identified potential global biomarkers of 
hPSC-CM maturation by performing univariate 
biomarker analysis. The metabolites which 
successfully discriminated between 1m hPSC-CMs 
and 3m hPSC-CMs in all cell lines tested were GPC, 
PC, GPC:PC ratio, pantothenate (Vit. B5), alanine, and 
glycine (Fig. 6A). We identified GPC and PC to be 
significantly increased and reduced, respectively, in 
3m hPSC-CMs as compared to 1m hPSC-CMs. In 
addition to GPC and PC, we observed a significantly 
lower abundance of pantothenate (Vit. B5), alanine, 
glycine and arginine in 3m hPSC-CMs as compared to 
1m hPSC-CMs. The complete results from univariate 
biomarker analysis can be found in Supplementary 
Table 1.  
 
Table 1. Results from two-way ANOVA using time and parent stem cell lines (parentSC) as factors.  
Metabolite p-value (Time) p-value (ParentSC) p-value (Interaction) 
sn-Glycero-3-phosphocholine 1.24E-18 N.S. 2.23E-05 
Alanine 1.13E-13 0.001639 0.000294 
O-Phosphocholine 6.21E-12 N.S. N.S. 
O-Acetylcarnitine 1.60E-11 1.34E-09 7.14E-12 
Carnitine 1.70E-11 N.S. 1.82E-05 
Creatine phosphate 1.27E-10 4.28E-05 2.06E-05 
L-Glutamine 2.22E-10 4.93E-06 0.025075 
Creatine 6.09E-10 1.10E-08 4.30E-09 
Choline 2.32E-09 2.52E-12 2.24E-13 
L-Glutamate 1.06E-07 0.000387 0.000133 
Citrate 1.93E-07 N.S. N.S. 
Fumarate 2.70E-07 N.S. N.S. 
Taurine 1.19E-06 1.09E-06 7.23E-10 
NAD 2.41E-06 N.S. 0.002093 
Lactate 4.55E-06 N.S. N.S. 
L-Proline 1.33E-05 3.46E-07 0.013639 
L-Arginine 1.91E-05 0.044202 0.024153 
trans-4-Hydroxy-L-proline 2.38E-05 N.S. 0.022452 
Pantothenate 2.56E-05 N.S. N.S. 
Glutathione 4.63E-05 N.S. N.S. 
L-Valine 5.55E-05 0.008681 N.S. 
L-Aspartate 8.94E-05 N.S. N.S. 
Glycerol 0.000158 4.23E-05 1.33E-05 
L-Leucine 0.000174 0.002168 0.0118 
L-Isoleucine 0.000202 0.010608 0.012144 
myo-Inositol 0.000887 0.022576 N.S. 
Succinate 0.001751 N.S. N.S. 
N-Acetylaspartate 0.002637 N.S. N.S. 
L-Serine 0.006592 N.S. N.S. 
Adenosine monophosphate 0.007973 N.S. N.S. 
Propionate 0.010346 N.S. N.S. 
L-Tyrosine 0.011349 N.S. N.S. 
Acetate 0.018459 N.S. N.S. 
L-Threonine 0.021882 N.S. N.S. 
L-Phenylalanine N.S. 0.001309 N.S. 
L-Methionine N.S. 0.000531 N.S. 
Adenosine diphosphate N.S. 0.001212 N.S. 
O-Phosphoethanolamine N.S. 0.046637 0.00039 
Adenosine triphosphate N.S. 0.048389 0.00613 
Time factor contained samples from day 6 progenitors, 1m hPSC-CMs and 3m hPSC-CMs organized in three groups representing time. For parentSC factor, the samples were 
delineated by three distinct hPSC lines. The two-factor analysis module in MetaboAnalyst was used to calculate the significance scores from two-way ANOVA (p-values) 
shown in the table. N.S.: not significant (p>0.05). 
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Figure 4. Metabolite-metabolite correlation analysis (MMCA) highlights differences in metabolic physiological states in 1m and 3m hPSC-CMs. The metabolic 
concentrations from (A) 1m and (B) 3m hPSC-CMs were used to evaluate pairwise Pearson correlation coefficients. The correlation table was imported in Cytoscape 
and Metscape plugin and the cut-off was set to 0.8 (p<0.01). Organic layout was used for plotting the network. The thickness of the edges is proportional to the 
magnitude of correlation coefficient and the color represents positive (red) or negative (blue) correlation coefficient. The size of the nodes is proportional to the 
degree of each node.  
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Table 2. Top 20 highest changes in metabolite-metabolite Pearson correlation coefficients in 1m hPSC-CMs vs. 3m hPSC-CMs.  
 
The color indicates positive (red) or negative (green) Pearson correlation coefficient between metabolite 1 and metabolite 2. Data represent 9 independent experiments. 
Abbreviations: PE: O-phosphoethanolamine. 
 
 
Since CoA synthesis is the primary mode of 
metabolism of pantothenate [34], we hypothesize that 
a significant reduction in pantothenate in 3m 
hPSC-CMs could indicate an increase in CoA demand 
and utilization in aged hPSC-CMs. Increased fatty 
acid oxidation in 3m hPSC-CMs may cause increased 
CoA utilization and therefore, a reduction in 
pantothenate could potentially serve as a biomarker 
for fatty acid oxidation. 
GPC and PC showed a time-dependent switch in 
abundance and the ratio of GPC to PC increased 
significantly with time in the hPSC-CMs (Fig. 6A and 
Supplementary Fig. S3A-C). GPC and GPC:PC were 
also significantly increased in samples of heart tissue 
from mice at two different developmental stages (day 
20 and 3m old mice) as shown in Fig. 6B and 
Supplementary Fig. S3D. Other putative metabolic 
biomarkers identified in hPSC-CMs in vitro (PC, 
pantothenate, alanine, and glycine) did not exhibit 
significant difference in heart tissues from mice at 
different stages of development (Fig. 6B). This may 
result from the differences in medium/extracellular 
nutrient conditions in vivo and in vitro. For example, 
alanine, glycine, and pantothenate are present in the 
cell culture medium and therefore, differences in 
extracellular concentrations in these metabolites could 
potentially lead to differences in intracellular 
concentrations.  
GPC and PC are both involved in phospholipid 
metabolism where PC is the precursor and GPC is the 
degradation product of phospholipids. Based on our 
enrichment analysis and MMCA, we demonstrated 
that glycerol phosphate shuttle and sphingolipid 
metabolism were significantly enriched in 3m 
hPSC-CMs. The implication of this increase in GPC 
and ratio of GPC:PC is currently not known but a 
reduction in GPC:PC has been observed in several 
cancers including breast cancer, prostate cancer and 
ovarian cancer [35–37]. A reduced GPC:PC ratio was 
also found to be strongly correlated with growth rate 
in estrogen-sensitive mammary tumors in rats [38]. 
Glunde et al. [39] showed that this switch was 
associated with an increase in choline kinase and 
phospholipase C activity in cancer cells. Choline 
kinase has been linked with the cell cycle [40] and 
since phospholipid synthesis is a key step during 
mitosis, GPC/PC ratio could be associated with 
proliferation in cancer cells. Whether these finding 
hold any relevance in cardiomyocytes is currently not 
known. Nonetheless, GPC, and GPC:PC can serve as 
biomarkers of maturation of CMs.  
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Figure 5. Pathway enrichment analysis identifies significantly enriched 
metabolic pathways upon extended hPSC-CM culture. Metabolite 
concentrations from 1m and 3m hPSC-CMs were compared with day 6 cardiac 
progenitors and the pathways significantly (FDR<0.1 and p<0.05) enriched in 
either 1m or 3m hPSC-CMs were included in the analysis. Grey color 
represents pathways which were not significantly enriched (FDR>0.1 or 
p>0.05). Q statistic was used to evaluate the level of enrichment.  
 
Conclusions 
In summary, we have validated that long term 
culture of hPSC-CMs to 3m can induce significant 
morphological, molecular and metabolic maturation 
as compared to 1m hPSC-CMs. We identified culture 
time-dependent and parent hPSC line-independent 
metabolic changes by studying metabolism in day 6 
cardiac progenitors, 1m hPSC-CMs, and 3m 
hPSC-CMs. Moreover, the metabolic changes between 
1m and 3m hPSC-CMs also led to significant changes 
in physiological metabolic states of hPSC-CMs. We 
identified several metabolic pathways which were 
differentially enriched in hPSC-CMs, some of which 
were known to be affected due to maturation while 
others including cofactor metabolism and 
phospholipid metabolism are described for the first 
time. Biomarker analysis revealed several potential 
metabolic biomarkers of hPSC-CM maturation, 
including GPC and GPC:PC ratio which successfully 
distinguished between 1m hPSC-CMs and 3m 
hPSC-CMs with high accuracy. The time-dependent 
changes in GPC and GPC:PC ratio were also observed 
in murine heart tissues at different developmental 
stages. Results from this study highlight changes in 
several metabolic pathways which may play a critical 
role in inducing or maintaining maturation. The 
biomarkers associated with maturation identified in 
this study can be used to test different strategies 
which hold potential for expediting the maturation 
process. Future studies will focus on investigating the 
relevance of differentially enriched metabolic 
pathways in maturation process and developing 
novel strategies to expedite the maturation process.  
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Figure 6. Potential biomarkers of maturation in hPSC-CMs and validation in mice hearts. A) The normalized and auto-scaled concentrations of top six metabolites 
which showed significant differences between 1m and 3m hPSC-CMs are shown with p values indicated. The red dotted line highlights the cut-off for distinguishing the 
two groups and achieving highest discrimination (based on receiver operating characteristic (ROC) curve analysis). B) Heart tissues from mice were isolated at day 
20 and 3 months and were used for metabolic profiling. The same six metabolite concentrations in 20 day old mice and 3m old mice heart tissues are shown. Student’s 
t-test was used to calculate the significance.  
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